Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 149

Results For "report"

1824 News Found

Merck announces leadership team for human health business
People | February 20, 2022

Merck announces leadership team for human health business

In the interim, Deepak Khanna will lead Human Health International.


Aizon’s CEO John Vitalie named one of the top 25 Biotech CEOs of 2022
News | February 19, 2022

Aizon’s CEO John Vitalie named one of the top 25 Biotech CEOs of 2022

The Healthcare Technology Report provides market research and insights, business news, investment activity updates and important corporate developments related to the healthcare technology sector


Hetero’s molnupiravir Phase III studies show 65 % reduction in hospitalisation
News | February 19, 2022

Hetero’s molnupiravir Phase III studies show 65 % reduction in hospitalisation

Early viral clearance (negative RT-PCR) and significant clinical improvement were observed within five days of administering the antiviral drug. There were no fatalities reported during the study


Jagsonpal Pharma inks agreement with Suvinys Developers
News | February 19, 2022

Jagsonpal Pharma inks agreement with Suvinys Developers

Suvinys Developers will supply dydrogesterone to Jagsonpal Pharma as per the terms and conditions mentioned in the agreement.


Tremfya achieves greater clinical responses in patients with ulcerative colitis
Biotech | February 19, 2022

Tremfya achieves greater clinical responses in patients with ulcerative colitis

Data from the Phase 2b QUASAR Induction Study showed approximately 60% of patients achieved the primary endpoint of clinical response, and approximately 30% showed endoscopic improvement with TREMFYA treatment compared with placebo


Covid-19 fuels innovative PCR-based detection methods
Medical Device | February 19, 2022

Covid-19 fuels innovative PCR-based detection methods

According to Fortune Business Insights, the launch of new PCR-based detection techniques will lead to a surge in demand for PCR instruments in the coming years


Natco Q3FY22 PAT up 27% to Rs 80 Cr
News | February 19, 2022

Natco Q3FY22 PAT up 27% to Rs 80 Cr

The company registered consolidated total revenue of Rs 590.70 crore for Q3FY22.


US FDA to review Amylyx new drug application for AMX0035
Drug Approval | February 19, 2022

US FDA to review Amylyx new drug application for AMX0035

AMX0035 is an investigational therapy for the treatment of amyotrophic lateral sclerosis (ALS).


Agilent acquires Virtual Control’s AI technology to enhance lab productivity
Digitisation | February 18, 2022

Agilent acquires Virtual Control’s AI technology to enhance lab productivity

Agilent will integrate the technology into its lab informatics platforms, enabling customers to automate GC/MS data analysis


Ligand posts strong 2021 performance
News | February 18, 2022

Ligand posts strong 2021 performance

Ligand expects 2022 royalties of $55 million to $60 million, material sales of $40 million to $50 million, and contract revenue of $52 million to $62 million.